Małujło-Balcerska Elżbieta, Kumor-Kisielewska Anna, Gałecka Maria, Pietras Tadeusz
Department of Pneumonology, Medical University of Łódź, Łódź, Poland.
Department of Pulmonology, Medical University of Łódź, Kopcińskiego 22, Łódź, 90-153, Poland.
Pharmacol Rep. 2025 Jun 19. doi: 10.1007/s43440-025-00754-1.
Different immune/inflammatory molecules play key roles in the development of inflammatory diseases, including chronic obstructive pulmonary disease (COPD). Thyroid hormones (THs) participate in immune/inflammatory reactions and may play a role in COPD. The main TH metabolism reactions are dependent on iodothyronine deiodinase (DIO). Accumulating evidence also supports the role of cytokines in TH metabolism-related factors. This cross-sectional, observational study investigated the levels of DIO and proinflammatory cytokines and their correlations with stable COPD.
A total of 55 participants, comprising 25 patients diagnosed with stable COPD and 30 control patients, were enrolled in this study. Cytokine and DIO levels were measured using commercially available human enzyme-linked immunosorbent assay (ELISA) kits from R&D Systems and My BioSource.
Increased levels of DIO1-3 and interleukin (IL)-1β, IL-6, tumor necrosis factor (TNF)-ɑ, and interferon (IFN)-ɣ were found. Correlation analysis revealed several significant correlations, including interdependence between DIO and cytokine levels, with strong correlations between DIO2 and IFN-ɣ levels and an association between the above protein levels and clinical data. The levels of DIO 1-3 and cytokines (IL-6, TNF-α, and IFN-γ) all showed a positive relationship with COPD relative risk, suggesting that higher levels of DIO and cytokines may influence COPD biology.
Findings from our novel study indicate that DIO and proinflammatory cytokines are possibly involved in the mechanisms underlying processes related to COPD, including immune-endocrine interaction. These can be discussed for further evaluation in COPD-related studies with more precise diagnostic and therapeutic monitoring of all confounding factors and a larger cohort.
不同的免疫/炎症分子在包括慢性阻塞性肺疾病(COPD)在内的炎症性疾病的发展中起关键作用。甲状腺激素(THs)参与免疫/炎症反应,可能在COPD中发挥作用。主要的TH代谢反应依赖于碘甲状腺原氨酸脱碘酶(DIO)。越来越多的证据也支持细胞因子在TH代谢相关因子中的作用。这项横断面观察性研究调查了DIO和促炎细胞因子的水平及其与稳定期COPD的相关性。
本研究共纳入55名参与者,包括25名诊断为稳定期COPD的患者和30名对照患者。使用R&D Systems和My BioSource的市售人类酶联免疫吸附测定(ELISA)试剂盒测量细胞因子和DIO水平。
发现DIO1 - 3以及白细胞介素(IL)-1β、IL-6、肿瘤坏死因子(TNF)-ɑ和干扰素(IFN)-ɣ水平升高。相关性分析揭示了几个显著的相关性,包括DIO与细胞因子水平之间的相互依赖,DIO2与IFN-ɣ水平之间的强相关性以及上述蛋白质水平与临床数据之间的关联。DIO 1 - 3和细胞因子(IL-6、TNF-α和IFN-γ)的水平均与COPD相对风险呈正相关,表明较高水平的DIO和细胞因子可能影响COPD生物学。
我们这项新研究的结果表明,DIO和促炎细胞因子可能参与了与COPD相关过程的潜在机制,包括免疫 - 内分泌相互作用。在COPD相关研究中,可以进一步讨论这些结果,以便对所有混杂因素进行更精确的诊断和治疗监测,并纳入更大的队列进行进一步评估。